title: Maintenance therapy with single-daily, high-dose mizoribine after cyclophosphamide therapy for prepubertal boys with severe steroid-dependent nephrotic syndrome.
authors.forename: Shuichiro
authors.initials: S
authors.lastname: Fujinaga
authors.forename: Amane
authors.initials: A
authors.lastname: Endo
authors.forename: Tsuneki
authors.initials: T
authors.lastname: Watanabe
authors.forename: Daishi
authors.initials: D
authors.lastname: Hirano
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Ohtomo
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Shimizu
authors.forename: Kazunari
authors.initials: K
authors.lastname: Kaneko
mesh_terms: D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007223:Infant; D060046:Maintenance Chemotherapy; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D012263:Ribonucleosides / Q000008:administration & dosage*; D013256:Steroids / Q000008:administration & dosage
chemical_list: D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D013256:Steroids; C010052:mizoribine; D003520:Cyclophosphamide